| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |